platinum has been researched along with Leukemia L 1210 in 48 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 31 (64.58) | 18.7374 |
1990's | 14 (29.17) | 18.2507 |
2000's | 2 (4.17) | 29.6817 |
2010's | 1 (2.08) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Berger, W; Galanski, MS; Göschl, S; Heffeter, P; Jakupec, MA; Jensen, F; Keppler, BK; Roller, A; Theiner, S; Varbanov, HP | 1 |
Balázová, E; Hrubisko, M; Ujházy, V | 2 |
Butour, JL; Macquet, JP | 1 |
Kidani, Y; Motoyama, S; Noji, M; Tashiro, T | 1 |
Kohn, KW; Micetich, K; Zwelling, LA | 1 |
Abiko, N; Maeda, M; Sasaki, T | 1 |
Kidani, Y; Noji, M; Okamoto, K; Tashiro, T | 1 |
Burchenal, JH; Irani, G; Kern, K; Lokys, L; Turkevich, J | 1 |
Cafaggi, S; Esposito, M; Parodi, B; Viale, M | 1 |
Deng, Y; Khokhar, AR; Kido, Y; Siddik, ZH | 1 |
Hoshi, A; Maeda, M; Suga, T; Takasuka, N; Uehara, N | 1 |
Khokhar, AR; Kido, Y; Siddik, ZH | 1 |
Chwalinski, T; Harrap, KR; Kelland, LR; O'Neill, CF; Ormerod, MG; Orr, RM; Titley, JC | 1 |
Jun, MJ; Kim, KM; Kim, YS; Sohn, YS; Song, R | 1 |
Chikuma, M; Komeda, S; Lutz, M; Reedijk, J; Sato, T; Spek, AL; Yamanaka, Y | 1 |
Aggarwal, SK; McAllister, PK; Rosenberg, B; Wagner, RW | 1 |
Atkins, LM; Glae, GR; Meischen, SJ; Smith, AB; Walker, EM | 1 |
Blackwell, LH; Loveless, VS; Morris, CR | 1 |
Atkins, LM; Gale, GR; Meischen, SJ; Schwartz, P | 1 |
Foye, WO; Kaewchansilp, V | 1 |
Bull, JM; Cysyk, R; Gormley, PE; LeRoy, AF | 1 |
Lewis, RW; Skinner, SM | 1 |
Burchenal, JH; Chisholm, J; Kalaher, K; O'Toole, T | 1 |
Beaumont, KP; Cleare, MJ; McAuliffe, CA | 1 |
Iakovlev, KI; Ivanov, VF; Konovalova, AL; Presnov, MA; Stetsenko, AI | 1 |
Atkins, LM; Frangakis, CJ; Gale, GR; Lake, LM; Meischen, SJ; Rosenblum, MG; Smith, AB; Walker, EM | 1 |
Atkins, LM; Gale, GR; Morris, CR | 1 |
Elliott, WL; Farrell, NP; Hoeschele, JD; Kraker, AJ; Sercel, AD; Showalter, HD | 1 |
Hata, G; Kaneko, T; Kawai, H; Kitano, Y; Mutoh, M | 1 |
Bois, C; Kozelka, J; Segal, E | 1 |
Harrap, KR; Nicolson, MC; O'Neill, CF; Orr, RM | 1 |
Farrell, N; Hacker, MP; Roberts, JD | 1 |
Basinger, MA; Holscher, MA; Jones, MM | 2 |
Farnworth, P; Hillcoat, B; Roos, I | 1 |
Khokhar, AR; Siddik, ZH; Xu, QY | 1 |
Hayashi, T; Katahira, J; Kitayama, R; Kumada, T; Kumano, K; Muratani, T; Saikawa, I; Shimizu, K; Watanabe, Y; Yasuda, T | 1 |
Maeda, M; Sasaki, T; Uchida, NA | 1 |
Belehradek, J; Foka, M; Paoletti, J | 1 |
Hanusovská, E; Ujházy, V | 1 |
Waud, WR | 1 |
Hanamura, S; Kidani, Y; Noji, M; Suzuki, K; Tashiro, T | 1 |
Carter, SK | 1 |
Gang, M; Kline, I; Sirica, AE; Venditti, JM; Woodman, RJ | 1 |
Atkins, LM; Gale, GR; Meischen, SJ; Smith, AB; Walker, EM | 1 |
Rosenberg, B; VanCamp, L | 1 |
Mansour, VH; Rosenberg, B; Trosko, JE; VanCamp, L | 1 |
1 review(s) available for platinum and Leukemia L 1210
Article | Year |
---|---|
Current status of new agents.
Topics: Alopecia; Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Azacitidine; Azaguanine; Carmustine; Cyclohexanes; Drug Combinations; Heart; Humans; Leukemia L1210; Nitrosourea Compounds; Platinum; Prednisone; Remission, Spontaneous | 1972 |
47 other study(ies) available for platinum and Leukemia L 1210
Article | Year |
---|---|
A novel class of bis- and tris-chelate diam(m)inebis(dicarboxylato)platinum(IV) complexes as potential anticancer prodrugs.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Chemistry, Physical; Colonic Neoplasms; Coordination Complexes; Crystallography, X-Ray; Drug Screening Assays, Antitumor; Humans; Hydrophobic and Hydrophilic Interactions; Leukemia L1210; Mice, Inbred BALB C; Mice, Inbred DBA; Mice, SCID; Models, Molecular; Organoplatinum Compounds; Oxidation-Reduction; Platinum; Quantum Theory; Structure-Activity Relationship; Thermodynamics | 2014 |
In vivo and in vitro effectivity of some platinum complexes.
Topics: Animals; Antineoplastic Agents; Carboplatin; Cell Line; Cisplatin; Drug Evaluation, Preclinical; Female; Injections, Intraperitoneal; Leukemia L1210; Leukemia P388; Leukemia, Experimental; Male; Mice; Mice, Inbred DBA; Organoplatinum Compounds; Platinum | 1984 |
Drug resistance induction and cross-resistance studies with Pt-complexes.
Topics: Animals; Antineoplastic Agents; Cell Division; Cell Line; Cisplatin; Drug Evaluation, Preclinical; Drug Resistance; Leukemia L1210; Mice; Organoplatinum Compounds; Platinum | 1984 |
Platinum-amine compounds: importance of the labile and inert ligands for their pharmacological activities toward L1210 leukemia cells.
Topics: Animals; Cell Division; Cells, Cultured; Female; Hydrolysis; Isomerism; Leukemia L1210; Ligands; Mice; Platinum; Structure-Activity Relationship | 1983 |
Synthesis and antitumor activity of Pt(II) complexes containing 2,3-diaminopropanol isomers.
Topics: Animals; Antineoplastic Agents; Leukemia L1210; Mice; Platinum; Propanolamines; Stereoisomerism | 1983 |
Quenching of DNA:platinum(II) monoadducts as a possible mechanism of resistance to cis-diamminedichloroplatinum(II) in L1210 cells.
Topics: Animals; Cisplatin; DNA; Drug Resistance; Kinetics; Leukemia L1210; Mathematics; Mice; Platinum | 1983 |
Synthesis of seleno- and thioguanine-platinum(II) complexes and their antitumor activity in mice.
Topics: Animals; Antineoplastic Agents; Chemical Phenomena; Chemistry; In Vitro Techniques; Leukemia L1210; Mice; Platinum; Selenium; Thioguanine | 1981 |
Preparation of platinum(II) complexes of diamine isomers [PtX(1,3-diamine)] (X = Cl2, SO4, (NO3)2, oxalato, D-glucuronato, and D-gluconato) and determination of their antitumor activity against leukemia L1210.
Topics: Animals; Antineoplastic Agents; Diamines; Leukemia L1210; Mice; Platinum | 1981 |
1,2-Diaminocyclohexane platinum derivatives of potential clinical value.
Topics: Animals; Antineoplastic Agents; Cells, Cultured; Cyclohexanes; Drug Resistance; Drug Therapy, Combination; Leukemia L1210; Leukemia, Experimental; Mice; Platinum | 1980 |
Cytotoxicity and cellular accumulation of a new cis-diammineplatinum (II) complex containing procaine in murine L1210 cells sensitive and resistant to cis-diamminedichloroplatinum (II).
Topics: Animals; Antineoplastic Agents; Cell Size; Cisplatin; DNA; Leukemia L1210; Mice; Organoplatinum Compounds; Platinum; Procaine; Spectrophotometry, Atomic; Structure-Activity Relationship; Tetrazolium Salts; Tumor Cells, Cultured | 1995 |
Preparation, characterization, and antitumor activity of new ethylenediamine platinum(IV) complexes containing mixed carboxylate ligands.
Topics: Animals; Antineoplastic Agents; Carboxylic Acids; Ethylenediamines; Leukemia L1210; Magnetic Resonance Spectroscopy; Mice; Molecular Structure; Platinum; Structure-Activity Relationship; Tumor Cells, Cultured | 1993 |
Antitumor activity of a new series of platinum complexes: trans(+/-)-1,2-cyclohexanediammineplatinum(II) conjugated to acid polysaccharides.
Topics: Animals; Chondroitin Sulfates; Cisplatin; Drug Screening Assays, Antitumor; Female; Half-Life; Leukemia L1210; Mice; Mice, Inbred Strains; Platinum; Polysaccharides | 1993 |
Differential cytotoxicity, uptake and DNA binding of tetraplatin and analogous isomers in sensitive and resistant cancer cell lines.
Topics: Animals; Antineoplastic Agents; Cell Division; Cisplatin; Colony-Forming Units Assay; DNA; Drug Resistance; Female; Humans; Isomerism; Leukemia L1210; Mice; Organoplatinum Compounds; Ovarian Neoplasms; Platinum; Tumor Cells, Cultured | 1993 |
The cytotoxic action of four ammine/amine platinum(IV) dicarboxylates: a flow cytometric study.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Survival; DNA, Neoplasm; Flow Cytometry; Leukemia L1210; Mice; Organoplatinum Compounds; Platinum | 1996 |
Synthesis, characterization and antitumor activity of quinolone-platinum(II) conjugates.
Topics: Animals; Antineoplastic Agents; Carboplatin; Fluoroquinolones; Leukemia L1210; Magnetic Resonance Spectroscopy; Models, Chemical; Molecular Structure; Nalidixic Acid; Oxolinic Acid; Platinum; Quinolizines; Quinolones; Spectrophotometry, Infrared; Tumor Cells, Cultured | 2001 |
A novel isomerization on interaction of antitumor-active azole-bridged dinuclear platinum(II) complexes with 9-ethylguanine. Platinum(II) atom migration from N2 to N3 on 1,2,3-triazole.
Topics: Animals; Antineoplastic Agents; Cisplatin; Crystallography, X-Ray; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Guanine; Hydrogen-Ion Concentration; Isomerism; Leukemia L1210; Mice; Nuclear Magnetic Resonance, Biomolecular; Organoplatinum Compounds; Platinum; Triazoles; Tumor Cells, Cultured | 2002 |
Cell-surface-associated nucleic acid in tumorigenic cells made visible with platinum-pyrimidine complexes by electron microscopy.
Topics: Animals; Carcinoma; Cattle; Cell Line; Cell Membrane; Cell Nucleolus; Chickens; Chromatin; Cricetinae; DNA; Fibroblasts; Humans; Leukemia L1210; Mice; Microscopy, Electron; Mouth Neoplasms; Platinum; Pyrimidines; Rats; Ribosomes; Sarcoma 180; Staining and Labeling; T-Lymphocytes | 1975 |
Combination chemotherapy of L1210 leukemia with platinum compounds and cyclophosphamide plus other selected antineoplastic agents.
Topics: Animals; Cell Survival; Cisplatin; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Evaluation, Preclinical; Drug Therapy, Combination; Fluorouracil; Leukemia L1210; Mesylates; Methotrexate; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Organometallic Compounds; Platinum; Propylamines; Vincristine | 1976 |
Antileukemic properties of combinations of radiation and malonato(1,2-diaminocyclohexane) platinum(ii) (NSC-224964).
Topics: Animals; Antineoplastic Agents; Cyclohexanes; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Evaluation Studies as Topic; Leukemia L1210; Mice; Organometallic Compounds; Platinum; Radiotherapy Dosage | 1977 |
Schedule-dependency assessments of ribonucleoside diphosphate reductase inhibitors when used in combination with platinum compounds plus cyclophosphamide in the treatment of advanced L1210 leukemia.
Topics: Animals; Cyclophosphamide; Drug Administration Schedule; Drug Therapy, Combination; Guanazole; Hydroxyurea; Isoquinolines; Leukemia L1210; Mice; Platinum; Ribonucleoside Diphosphate Reductase; Ribonucleotide Reductases; Thiosemicarbazones | 1979 |
Mercaptoalkylamine coordination compounds of platinum(II) and palladium(II) and their anticancer activity.
Topics: Animals; Antineoplastic Agents; Leukemia L1210; Mice; Palladium; Platinum; Spectrophotometry, Infrared; Sulfhydryl Compounds | 1979 |
Kinetics of cis-dichlorodiammineplatinum.
Topics: Animals; Blood Proteins; Breast Neoplasms; Cell Survival; Cisplatin; Female; Humans; In Vitro Techniques; Kinetics; Leukemia L1210; Mice; Ovarian Neoplasms; Platinum; Protein Binding | 1979 |
Anti leukemia activity (L1210) of 6-mercaptopurine and its metallo complexes in mice.
Topics: Animals; Bismuth; Leukemia L1210; Mercaptopurine; Mice; Mice, Inbred Strains; Organometallic Compounds; Palladium; Platinum | 1977 |
Lack of cross-resistance between certain platinum coordination compounds in mouse leukemia.
Topics: Animals; Cells, Cultured; Cisplatin; Cyclohexanes; Drug Resistance; Leukemia L1210; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Organometallic Compounds; Organoplatinum Compounds; Platinum; Structure-Activity Relationship | 1977 |
Platinum complexes of substituted ethylenediamines and their anti-tumour activity.
Topics: Animals; Drug Evaluation, Preclinical; Ethylenediamines; Female; Leukemia L1210; Mice; Neoplasms, Experimental; Platinum; Sarcoma 180; Spectrophotometry, Infrared; Structure-Activity Relationship | 1976 |
[Antineoplastic properties of complex compounds of platinum(II)].
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; L-Lactate Dehydrogenase; Leukemia L1210; Lung Neoplasms; Mammary Neoplasms, Experimental; Mice; Neoplasm Transplantation; Neoplasms, Experimental; Platinum; Syndrome | 1976 |
Antileukemic properties of organoplatinum complexes.
Topics: Animals; Antineoplastic Agents; Chemical Phenomena; Chemistry; Cisplatin; Cyclophosphamide; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy, Combination; Leukemia L1210; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Organometallic Compounds; Platinum; Solubility; Water | 1976 |
The effects of single administration of an antitumor platinum compound on ornithine decarboxylase activity in certain tissues of mice bearing L1210 leukemia.
Topics: Animals; Carboxy-Lyases; Kidney; Leukemia L1210; Liver; Mice; Organometallic Compounds; Ornithine Decarboxylase; Platinum; Spleen; Urinary Bladder | 1976 |
Anticancer activity in murine and human tumor cell lines of bis(platinum) complexes incorporating straight-chain aliphatic diamine linker groups.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cisplatin; Colonic Neoplasms; Diamines; Drug Resistance; Humans; Leukemia L1210; Leukemia, Experimental; Lung Neoplasms; Malonates; Mammary Neoplasms, Experimental; Melanoma, Experimental; Mice; Mice, Nude; Molecular Structure; Platinum; Structure-Activity Relationship; Tumor Cells, Cultured | 1992 |
Synthesis, structure and antitumor activity of a water-soluble platinum complex, (1R,3R,4R,5R)-(-)-quinato(1R,2R-cyclohexanediamine)platinum (II).
Topics: Animals; Antineoplastic Agents; Leukemia L1210; Mice; Mice, Inbred Strains; Organoplatinum Compounds; Platinum; Quinic Acid | 1992 |
Cytotoxic activity of platinum (II) complexes with tri-n-butylphosphine. Crystal structure of the dinuclear hydrazine-bridged complex, cis,cis-[PtCl(PBu3n)2(mu-N2H4)PtCl(PBu3n) 2] (ClO4)2.2CHCl3.
Topics: Animals; Antineoplastic Agents; Crystallization; Hydrazines; Leukemia L1210; Magnetic Resonance Spectroscopy; Methanol; Methylene Chloride; Mice; Mice, Inbred DBA; Molecular Structure; Organometallic Compounds; Phosphines; Platinum; Solutions; Spectrophotometry, Ultraviolet; Tumor Cells, Cultured; X-Ray Diffraction | 1992 |
The role of platinum uptake and glutathione levels in L1210 cells sensitive and resistant to cisplatin, tetraplatin or carboplatin.
Topics: Animals; Antineoplastic Agents; Carboplatin; Cisplatin; Drug Resistance; Glutathione; Leukemia L1210; Mice; Organoplatinum Compounds; Platinum; Sensitivity and Specificity; Tumor Cells, Cultured | 1992 |
Shikimic acid complexes of platinum. Preparation, reactivity, and antitumor activity of (R,R-1,2-diaminocyclohexane) bis(shikimato) platinum(II). Evidence for a novel rearrangement involving platinum-carbon bond formation.
Topics: Animals; Antineoplastic Agents; Carbon; Chromatography, High Pressure Liquid; Cyclohexenes; Leukemia L1210; Leukemia P388; Magnetic Resonance Spectroscopy; Melanoma, Experimental; Organoplatinum Compounds; Platinum | 1991 |
Relative effectiveness of some compounds for the control of cisplatin-induced nephrotoxicity.
Topics: Animals; Carcinoma 256, Walker; Cisplatin; Drug Administration Schedule; Female; Kidney Diseases; Leukemia L1210; Mice; Mice, Inbred DBA; Platinum; Rats; Rats, Inbred Strains; Sulfur | 1991 |
Metallothionein-like proteins and cell resistance to cis-dichlorodiammineplatinum(II) in L1210 cells.
Topics: Animals; Cadmium; Cisplatin; Copper; Drug Resistance; Leukemia L1210; Metallothionein; Mice; Platinum; RNA, Messenger; RNA, Neoplasm; Sulfates; Tumor Cells, Cultured; Zinc; Zinc Sulfate | 1990 |
L-methionine suppresses pathological sequelae of cis-platinum in the rat.
Topics: Animals; Blood Urea Nitrogen; Bone Marrow; Carcinoma 256, Walker; Cisplatin; Creatinine; Female; Kidney; Leukemia L1210; Methionine; Platinum; Rats; Rats, Inbred Strains; Spleen; Thymus Gland | 1990 |
Synthesis, characterization, and antitumor activity of 1,2-bis(diphenylphosphino) ethane platinum(II) and palladium(II) complexes.
Topics: Animals; Antineoplastic Agents; Chemical Phenomena; Chemistry; Leukemia L1210; Magnetic Resonance Spectroscopy; Mice; Mice, Inbred Strains; Organometallic Compounds; Organophosphorus Compounds; Organoplatinum Compounds; Palladium; Platinum; Spectrophotometry, Infrared | 1990 |
Protective effect of piperacillin against the nephrotoxicity of cisplatin in rats.
Topics: Animals; Blood Urea Nitrogen; Cisplatin; Fosfomycin; Kidney; Kidney Diseases; Leukemia L1210; Male; Piperacillin; Platinum; Rats; Rats, Inbred F344 | 1989 |
Liposoluble platinum(II) complexes with antitumor activity.
Topics: Animals; Antineoplastic Agents; Cisplatin; Iodized Oil; Leukemia L1210; Mice; Mice, Inbred Strains; Pharmaceutical Vehicles; Platinum; Solubility | 1986 |
Interaction of cis-diamminedichloroplatinum(II) with sensitive and resistant L1210 cell lines. Drug binding to nuclei and DNA.
Topics: Animals; Cell Nucleus; Cisplatin; DNA; Drug Resistance; Leukemia L1210; Mice; Mice, Inbred DBA; Platinum; Tumor Cells, Cultured | 1988 |
DNA synthesis, protein synthesis and platinum content following drug administration in cis-diamminedichloroplatinum(II) -sensitive and -resistant L1210 cells transferred from in vitro to in vivo conditions.
Topics: Animals; Cell Line; Cisplatin; DNA, Neoplasm; Drug Resistance; Leukemia L1210; Mice; Mice, Inbred DBA; Mutation; Neoplasm Transplantation; Platinum; Protein Biosynthesis; Thymidine | 1987 |
Differential uptake of cis-diamminedichloroplatinum (II) by sensitive and resistant murine L1210 leukemia cells.
Topics: Animals; Chromatography, High Pressure Liquid; Cisplatin; DNA; Drug Resistance; Leukemia L1210; Mice; Platinum; Time Factors; Tumor Cells, Cultured | 1987 |
Antitumor activity of Pt(II) complexes containing diaminocarboxylates and their ester derivatives.
Topics: Animals; Antineoplastic Agents; Chemical Phenomena; Chemistry; Leukemia L1210; Mice; Mice, Inbred Strains; Platinum | 1986 |
The enhanced therapeutic effect of cis-platinum (II) diamminodichloride against L1210 leukemia when combined with cyclophosphamide or 1,2-bis(3,5-dioxopiperazine-1-yl)propane or several other antitumor agents.
Topics: Amines; Animals; Antineoplastic Agents; Azacitidine; Camptothecin; Carmustine; Chlorides; Cyclophosphamide; Cytarabine; Drug Synergism; Emetine; Fluorouracil; Ketones; Leukemia L1210; Male; Methotrexate; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Piperazines; Platinum; Propane; Time Factors | 1973 |
Antitumor action of dichloro(4,5-dimethyl-0-phenylenediamine-N',N')platinum(II).
Topics: Aniline Compounds; Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Chlorine; DNA; In Vitro Techniques; Leucine; Leukemia L1210; Mice; Platinum; Protein Biosynthesis; RNA; Thymidine; Tritium; Uridine | 1973 |
The successful regression of large solid sarcoma 180 tumors by platinum compounds.
Topics: Animals; Body Weight; Leukemia L1210; Mice; Neoplasm Transplantation; Platinum; Sarcoma 180 | 1970 |
Platinum compounds: a new class of potent antitumour agents.
Topics: Animals; Antineoplastic Agents; Leukemia L1210; Mice; Platinum; Sarcoma 180 | 1969 |